Federal judge blocks $602M in CDC cuts to 4 states

Kelly Gooch / beckershospitalreview - A federal judge in the Northern District of Illinois granted a temporary restraining order Feb. 12 blocking the Trump administration from terminating more than $600 million in CDC-administered public health grants to California, Colorado, Illinois and Min…

AI Summary: A federal judge issued a temporary restraining order halting the administration’s planned termination of roughly $600M in CDC grants to several states, siding with lawsuits that argued the cuts would impair public-health programs. The order preserves funding while courts consider claims that the move would cause immediate harm.

FDA refuses to review Moderna flu vaccine

Ella Jeffries / beckershospitalreview - Moderna has received a refusal-to-file letter from the FDA’s Center for Biologics Evaluation and Research for its biologics license application for mRNA-1010, its investigational seasonal influenza vaccine. The letter, signed by Vinayak Prasad, MD, chief …

AI Summary: Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making.

Glyphosate: What Indigenous communities have suspected for years about the dangers of the herbicide

Charles Z. Levkoe, Canada Research Chair in Equitable and Sustainable Food Systems, Lakehead Univers / theconversation - The recent retraction of peer-reviewed research claiming glyphosate is safe confirms what Indigenous communities have said for years.

AI Summary: The recent retraction of a widely cited study asserting glyphosate’s safety has rekindled long‑held Indigenous suspicions about the herbicide. Experts now question its safety profile, calling for more regulatory scrutiny and a re‐evaluation of long‑standing warnings regarding its potential dangers.

Public Health Department confirms first 2026 measles case in Los Angeles County

medicalxpress - The Department of Public Health has confirmed the first measles case this year in Los Angeles County. Officials say the person who tested positive for measles had recently traveled outside the country. The department is now working to identify people who …

AI Summary: Los Angeles County health officials confirmed the first measles case of 2026 even as nationwide data reveal that only one month into the year, case numbers have already reached 25% of 2025’s total. Experts warn that if vaccination rates do not improve promptly, an early outbreak could expand and stress public health systems.

HHS launches $100M homelessness, addiction treatment initiative

Ella Ruder / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. unveiled a $100 million federal initiative to address homelessness, opioid addiction and public safety following President Donald Trump’s executive order creating the Great American Recovery Initiative. The Safety Throu…

AI Summary: Two nearly identical reports detail a new federal announcement by HHS, which unveiled a $100M initiative aimed at tackling homelessness among individuals with addiction issues. The program is designed to integrate mental health, addiction treatment, and social services to rapidly stabilize vulnerable populations.

MultiCare agrees to $3.7M settlement over allegations it knowingly allowed unnecessary surgeries

fiercehealthcare - The DOJ said MultiCare had allowed a former physician to perform spinal surgery procedures at its facilities between 2019 and 2021 despite warnings from two employees and the U.S. Attorney's Office.

AI Summary: Federal investigators found that MultiCare knowingly allowed a former physician to perform unnecessary spinal surgeries despite multiple warnings, prompting a whistleblower lawsuit. In response, the health system agreed to a $3.7 million settlement to resolve the allegations and avoid further litigation.

HHS to drop 340B rebate pilot after court rulings

Ella Jeffries / beckershospitalreview - HHS will drop its 340B rebate model pilot program following two federal court rulings that blocked its implementation. The program, announced in August 2025, was challenged by the American Hospital Association, the Maine Hospital Association and four safe…

AI Summary: In a twist that no one saw coming (except the federal courts), HHS has scrapped its controversial 340B rebate pilot after two judicial rulings blocked its implementation. Providers, relieved to avoid a potential cash flow nightmare, are quietly celebrating the decision as one less bureaucratic headache to manage.

#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial

Ayisha Sharma / endpoints - Bayer shared more details from its unexpected win in a Phase 3 study testing its next-generation blood thinner for secondary stroke prevention. The factor XIa inhibitor, named asundexian, reduced the occurrence of ischemic stroke by ...

AI Summary: Bayer’s latest Phase 3 study of asundexian has shown a 26% reduction in secondary ischemic stroke risk—without an increased bleeding risk. This compelling data bolsters the drug’s prospects as a blockbuster in stroke prevention and underscores Bayer’s commitment to advancing cardiovascular therapies.

AI model reads brain MRIs in seconds, hitting up to 97.5% accuracy

medicalxpress - An AI-powered model developed at the University of Michigan can read a brain MRI and diagnose a person in seconds, a study suggests. The model detected neurological conditions with up to 97.5% accuracy and predicted how urgently a patient required treatme…

AI Summary: Researchers at the University of Michigan have unveiled an AI-powered model that reads brain MRIs in seconds with up to 97.5% accuracy. This breakthrough promises to ease radiologist workloads and dramatically speed up neurodiagnostics, potentially transforming clinical workflows in imaging.

Eikon Therapeutics Raises $381 M in IPO to Advance Live-Cell Imaging in Cancer Drug Discovery

oncodaily - Eikon Therapeutics has raised $381 million through its IPO, pricing at the top of its range in a strong sign of renewed investor appetite for biotech offerings. The South San […]

AI Summary: Eikon Therapeutics successfully raised $381 million in its IPO, reinforcing investor confidence in novel biotechnology approaches for cancer drug discovery. The fundraising milestone is expected to accelerate live‐cell imaging and other innovative oncology research initiatives.

High Consumption of Ultraprocessed Foods May Be Linked to Cancer Survivors’ Risk of Death

Kathleen Medora / aacr - PHILADELPHIA – Cancer survivors who consumed higher amounts of ultraprocessed foods as part of their diet had a significantly increased risk of both all-cause and cancer-specific death, according to a study published in Cancer Epidemiology, Biomarkers & P…

AI Summary: Recent research from a Philadelphia‐based study indicates that cancer survivors consuming high amounts of ultraprocessed foods face significantly increased risks of both overall and cancer‐specific death. Experts stress that optimizing diet post‐treatment is critical for improving long‐term outcomes.

A newborn's death likely linked to the mom drinking raw milk while pregnant

go - Health officials in New Mexico have said a newborn baby died from a listeria infection likely linked to the child's mother drinking raw milk during pregnancy

AI Summary: New Mexico health officials report a tragic newborn death attributed to a listeria infection linked to the mother’s consumption of unpasteurized raw milk during pregnancy, re–igniting long–standing concerns about food safety standards and the risks involved in consuming unregulated dairy products.

HHS scraps 340B rebate pilot in win for hospitals

Emily Olsen / healthcaredive - The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates on some drugs instead of upfront discounts.

AI Summary: Federal health officials have reversed course on a highly controversial 340B rebate pilot program after federal courts blocked its implementation – a move hailed by providers as a long‐awaited relief from cash flow and administrative burdens.

Statin pills much safer than advertised, major review finds

bbc - The results, in The Lancet journal, come from trials involving more than 120,000 people comparing statins with a dummy drug or placebo.

AI Summary: Multiple large‐scale analyses have debunked the long‐held worries about statin side effects – it turns out that those pesky symptoms listed on package leaflets are no more common than when taking a placebo. In other words, patients can keep calm and lower cholesterol with confidence.

Plastic Surgeons’ Group Advises Delaying Gender-Affirming Procedures Until Age 19

Andrew Jacobs / nytimes - The organization’s latest guidance is a departure from the prevailing views of several other major medical organizations.

AI Summary: Multiple reports confirm that the American Society of Plastic Surgeons is advising that elective gender‐affirming procedures for minors be delayed until patients reach age 19. The recommendation diverges from other medical group views and aims to enhance patient safety by waiting until later adolescence for irreversible surgical interventions.

FTC deal over insulin prices forces Express Scripts to overhaul policies

Elizabeth Casolo / beckershospitalreview - The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. Under the settlement, Express Scripts must keep drug manufacturer compensation de…

AI Summary: Federal regulators reached a settlement with Express Scripts amid long‐standing allegations that the pharmacy benefit manager overcharged for insulin. The deal forces sweeping policy revisions to curb price inflation and protect patients from rising costs, following years of regulatory scrutiny over insulin rebate practices.

Meditech founder and EHR innovator A. Neil Pappalardo dies at 83

fiercehealthcare - Pappalardo is considered a tech pioneer with a 56-year career that started when he founded electronic health record company Meditech in 1969, a company he steered to become one of the leading EHR companies.

AI Summary: Tech pioneer A. Neil Pappalardo – the founder of Meditech whose 56‐year career revolutionized electronic health records – has passed away at 83. His contributions reshaped healthcare IT and continue to influence clinical practice worldwide.

Sarbajit Mukherjee: Who Truly Benefits from Perioperative Immunotherapy in Gastric and GEJ Cancer?

oncodaily - Sarbajit Mukherjee, Chief of GI Medical Oncology at Miami Cancer Institute and Co-Chair of GI Clinical Trial Working Group at Hoosier Cancer Research Network, shared a post on LinkedIn about a recent […]

AI Summary: Multiple alerts from health authorities emphasize that the physical exertion of shoveling heavy snow in frigid conditions can spike cardiovascular risk. With reports echoing similar cautions, experts advise caution and proper pacing while clearing snow to avoid strain on the heart.

India says it has contained Nipah virus outbreak as some Asian countries ramp up health screenings

go - Indian authorities have contained a Nipah virus outbreak after confirming two cases in eastern West Bengal state

AI Summary: Indian health authorities report that a recent Nipah virus outbreak in West Bengal – marked by two confirmed cases – has been successfully contained. In response, airports and health officials have stepped up screenings to curb further spread, highlighting growing regional vigilance in controlling the outbreak.